Ask AI

Research Focus in Relapsed/Refractory Follicular Lymphoma: Emerging Insights on Novel Bispecific Antibodies

Improve your understanding of new and emerging bispecific antibodies used to manage relapsed/refractory follicular lymphoma to enhance patient care through a podcast, expert-written ClinicalThought commentary, and certified text module with accompanying downloadable slides.

Share

Program Content

Activities

Bispecific Antibodies for FL
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: September 12, 2025

Expires: March 11, 2026

Activities

BsAbs in RR FL
Bispecific Antibodies in Relapsed/Refractory Follicular Lymphoma: Efficacy, Toxicities, and Practical Implementation
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: February 03, 2026

Expires: August 02, 2026

Activities

BsAbs in RR FL
Bispecific Antibodies in Relapsed/Refractory Follicular Lymphoma: Efficacy, Toxicities, and Practical Implementation
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 03, 2026

Activities

BsAbs in FL
Advancing Follicular Lymphoma Treatment: Clinical Integration of Bispecific Antibodies Across Lines of Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2026

Expires: August 22, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Regeneron Pharmaceuticals, Inc. 

Regeneron Pharmaceuticals, Inc